An indolocarbazole compound, NB-506, inhibits the activity of topoisom
erase 1 by stabilizing the DNA-topoisomerase 1 complex (cleavable comp
lex). NB-506 inhibited the religation step of topoisomerase 1 activity
more potently than camptothecin or its derivative, topotecan. A cleav
age assay using an end-labeled fragment of DNA revealed that the patte
rn of cleavage induced by NB-506 was different from that induced by ca
mptothecin. The preferred cleavage sites of NB-506 were found to be no
t only T but also A or C at the 3'-terminus of the cleaved DNA (positi
on -1), while the DNA cleavage sites of camptothecin always had T at p
osition -1. At the 5'-terminus of the cleaved DNA (position + 1), NB-5
06 showed a preference for G, which is a feature shared in common with
camptothecin. Therefore, the difference in cleavage patterns was most
likely due mainly to the preferred base at position -1. Moreover, the
re-ligation rate was significantly slower at NB-506-selective sites,
which had C at position-1, than at camptothecin-selective sites or at
sites cleaved by both NB-506 and camptothecin. Our data suggest that N
B-506 is an unique topoisomerase 1 poison and that its potent inhibiti
on of topoisomerase 1 is partly dependent on retardation of re-ligatio
n at sites selectively induced by NB-506. (C) 1998 Wiley-Liss, Inc.